Skip to content

Clinical trials

Terminated Phase 2 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Status: Terminated Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20037
20045
20055
200616
20078
20088
20096
20106
20113
20124
20133
20147
20158
20163
20174
20185
20196
20207
20213
20225
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated132

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center8
National Cancer Institute (NCI)4
SWOG Cancer Research Network4
Barbara Ann Karmanos Cancer Institute3
Burzynski Research Institute3
European Organisation for Research and Treatment of Cancer - EORTC3
H. Lee Moffitt Cancer Center and Research Institute3
Mayo Clinic3
Pharmacyclics LLC.3
UNC Lineberger Comprehensive Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms132
Carcinoma, Non-Small-Cell Lung67
Neoplasm Metastasis15
Adenocarcinoma of Lung14
Breast Neoplasms12
Small Cell Lung Carcinoma11
Brain Neoplasms7
Adenocarcinoma, Bronchiolo-Alveolar6
Esophageal Neoplasms5
Neoplasms5

Trials

Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.